ORIC Pharmaceuticals (4TZ.F) Q3 2024 Earnings

12AugConfirmed
Q4 2023
Q2 2024
Q3 2024
-0.45
-0.41
-0.38
-0.34

Details

Expected EPS
-0.37714887131999997
Actual EPS
-0.411489
Surprise EPS
-0.03
Surprise Percent
+9.11%

Description

ORIC Pharmaceuticals (4TZ.F) has reported earnings of -0.411489 per share for Q3 2024.

0 Comments

Share your thoughts